Meeting
2024 ASCO Genitourinary Cancers Symposium
Novel molecular aberrations involved in testicular germ cell tumor (TGCT) development and cisplatin resistance.
Authors
Ludmila Boublikova
Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol; Department of Oncology, 1st Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
Ludmila Boublikova , Laura Matouskova , Violeta Bakardjieva-Mihaylova , Martina Zwyrtkova , Karolina Skvarova-Kramarzova , Jan Stuchly , Sona Krivonoskova , Blanka Rosova , Jan Trka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 520)
DOI
10.1200/JCO.2024.42.4_suppl.520
Abstract #
520
Poster Bd #
L22
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Olaparib as salvage treatment for advanced germ cell tumors after chemotherapy failure: Results of the open-label, single-arm, IGG-02 phase II trial.
First Author: Ugo De Giorgi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The role of serial circulating tumor DNA for predicting clinical outcomes of chemotherapy in patients with advanced gastric cancer.
First Author: Sheehyun Kim
Poster
2022 ASCO Genitourinary Cancers Symposium
A phase II trial evaluating the efficacy of cabozantinib in the treatment of patients with refractory germ-cell tumors (GCT).
First Author: Jennifer King
Poster
2021 ASCO Annual Meeting
Efficacy of TIP (paclitaxel, ifosfamide and cisplatin) as salvage chemotherapy for relapsed germ cell cancer patients stratified by the modified International Prognostic Factors Study Group (IPFSG) score: The Northern Ireland (NI) Experience.
First Author: Adam Uprichard